VA albuquerque lenalidomide do
Active Awarded Last action
- Contract number
- 36C26226N0305
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $2,071,263
Award facts
- Contract value 100% obligated
- $2,071,263.00 Current and potential, with all options
- Completion date 77% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $2,071,263 |
About this award
Veterans Integrated Service Network 22 issued a BPA call to Exelan Pharmaceuticals Inc. on January 15, 2026 for Lenalidomide pharmaceutical products with a ceiling value of $2,071,263.
The call is placed against Exelan's Blanket Purchase Agreement with Veterans Integrated Service Network 22 for Lenalidomide products. Work is performed at Boca Raton, Florida. The call is structured as firm fixed price and has an ultimate completion date of January 14, 2027. The deliverable involves Lenalidomide in various strengths and formulations to support oncology and hematologic malignancy treatment protocols across the VA healthcare system. The call carries no set-aside designation and competes on an unrestricted, fully open basis.
Quick answers
Who was awarded contract 36C26226N0305?
36C26226N0305 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on January 15, 2026.
How much is contract 36C26226N0305 worth?
The government has obligated $2,071,263 on 36C26226N0305.
Is contract 36C26226N0305 an order under another contract?
Yes. 36C26226N0305 is a BPA call under 36F79720D0227-36C26226A0006, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26226N0305 competed?
The extent of competition for 36C26226N0305 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award